Valsartan NDC 50228-132

NDC codes

FDA NDC Directory

Product NDC (as listed)50228-132Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50228-0132Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50228-132-05	50228013205	500 TABLET in 1 BOTTLE (50228-132-05)Marketed from Oct 27, 2021
50228-132-30	50228013230	30 TABLET in 1 BOTTLE (50228-132-30)Marketed from Oct 27, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Valsartan
Generic name (nonproprietary): valsartan
Active ingredients: Valsartan — 320 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ScieGen Pharmaceuticals, INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204038
Marketing start: Oct 27, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 50228-132_32318eee-6c28-4ec7-8a20-2089c6bd33ebSPL ID 32318eee-6c28-4ec7-8a20-2089c6bd33ebSPL set ID 1a8af3d9-4053-4233-82a7-e8c7bc9e302fRxCUI 349199, 349200, 349201, 349483UNII 80M03YXJ7IUPC 0350228134309, 0350228133302, 0350228135108, 0350228133906, 0350228132909, 0350228135306, 0350228134903, 0350228132305
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450228013205 followed by a unit qualifier and the quantity

Package 50228-0132-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension , to lower blood pressure in adults and children 1 year and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II-IV), to reduce hospitalization for heart failure in adults ( 1.2 ) Post-myocardial infarction, for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the treatment of hypertension, to lower blood p…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204038

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204038
Product	Strength	Form · route	Labeler	Product NDC
Valsartan	Valsartan 80 mg/1	TabletOral	ScieGen Pharmaceuticals, INC.	50228-134
Valsartan	Valsartan 160 mg/1	TabletOral	ScieGen Pharmaceuticals, INC.	50228-133
Valsartan	Valsartan 40 mg/1	TabletOral	ScieGen Pharmaceuticals, INC.	50228-135